Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

stbes eoaaea elt itdo -tlinsbut tliecak herena ltsuer iny iprmna$xaa otnnhlgot nmaaEgdmse yemeaac-l ssjsthbn tHen0tngiltido nsnmfnetdaseo, A.e nm ahlidpfGi’np mi cudc ereohtieMsr ocscheehi1taplthoc0 si
nstadrnmarrle,tarrei denerlsdaectoeddeaitlihcof tslkalrnurnt4ius:a yh ishoeu rrerynt si,l eh hstedea i,nw r eeb sepnlti aot,l am, cat Tsio e mahuumhohceJpiysatgro w ,uwnrgicawt ia stseod awmi.rdsg.rni fo atcr enoCo% h am 1 ysk nn adkrafo etipesavsrQbsd Joeeohroehsb fac et mkmate
eil vmttogttp,td lcis“ pmebee iesvweni mdta ept ion ua rlxaonricirouEnoayteaTlt ergi,ca csrrfteoat syaaeteiernne ns c supscifU.ftotnonaoeb rpc efClolu ny rs eaiaaitwfsn feii aiorddoeie. riinp,naen tas eleP wlr deteo o uno tnd ireoroi nhenaogrttteobwdiad.r Uvehiaaor a“Eso t aterttrotcnyroinbpaci”l,ct oicl iid oobs aaderasefiits SG e thotoeooot r Qooeecv lmidaSed rlaani no ouneans n fmthTeroritbae cnatco”rseoivtt rnttispn.rrtoeoonop tni en enwaQterrif dede oi a ocE. ieM aera, ingl,l rahw t anowfp rrnee.teafitntoa v eCeDbBn eucertvphdkHd nv v
o $ tnac2e pmspTl tn0o aoscornpoaoeiwd ouhuo ttiei .inxenslme-s semwrnwt0n ces ooeha t meoh alunst tnife ndaElil es popm samIpcr troomnpd
erllcsnto.aeigtlwECetpE u fgrmgno "e-rlsl/r -ne>s a1 Jrtme o hyn urat$ohOd-o tosoauei- ,tst i $tielen2ri, seydsrtrlwarecAfsflolaeiwsuancQist.s 5lr".tfdmd uoas0 :lcf/a-cniilrarwinfoa
s ee 0odCmneasccanweiloitroagrs$ tonam dee oufehoaoatre s btogd ee d acl totstrafiao telok oouurtslyisp.Et0r.osen sEoeree ueEfpimer n scndlnci vmrsi na for n gl nntndoamp slnemnoe n mtniao ushhhloEsis drrlchetse ulenjefrcaeb iuas taiee f defsoth as n x xeiclif’lims ertx1cirsrebosoielinQiraitnca
UpatainnCs nnupalbaoiis ,a e yepi Ci eeo ra,s gxtp ir nsih2oswpktas,hir a Qb tyAda hrtiortguuaelm6rrce nn ssoo.aauaim oot0douuh r pin eia,atpo tddpr lKie Eoenietnei dldmJunnT dnltaUgtnotacstgeng2, in
dinriio ri yiha msiciltmear Egrerl aro r,an haZ eoevdkaetetsteantoKd f Mgiysrnnvnaetigcao ede dayrcsarma ntsDomaMrdtedmrg f pe li oittot.ete —ooci—dhU leyVelil Ant poidatedsrlnenaont ns’o
aaai adahe.v ei,n,rB a,y chmeiUE ZChrdsaiKte .aniS lai no lJtis daa, tpotsln U dzne apnen .,twltnbe Uaea
n m eibe ystnntenfmietlxlnrtZnekhwahtat sIrnto il mhsr waweteareaieeeata ratanbe raosl htvn”es til.fcv ee e dio,renwrglrraliii eaeW tail m,tniheesd eiga oliepenoaedhsanu,aR“ c is,rd rEalee poo hm dlawtie uotv tc Cr t git
Please enable JavaScript to view this content.
Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.
One thought on “Elanco reports pet parasite treatment quickly hit $100M blockbuster status”
You must be logged in to post a comment.
Big business news. Teeny tiny price. $1/week Subscribe Now
Big business news. Teeny tiny price. $1/week Subscribe Now
Big business news. Teeny tiny price. $1/week Subscribe Now
Big business news. Teeny tiny price. $1/week Subscribe Now
One would think a business journal would, in this story, include information about Elanco’s stock performance. (It closed today at $19.05 today, up 3.36 percent from Friday’s close.)